Ono Pharmaceutical Announces Establishment of Strategic Alliance Headquarters

01-Mar-2007

Ono Pharmaceutical Co., Ltd. announced that as of March 1, 2007 the Discovery Research Alliance of the Research Headquarters and the International Business of the Development Headquarters will be integrated in a constructive way into one unit to establish a Strategic Alliance Headquarters.

In order to achieve its goal of serving as an R&D-oriented, international pharmaceutical company (global speciality) specializing in defined areas of research based on unique idea of "compound oriented" that is totally different from other companies in the industry, Ono has striven to discover original and innovative new drugs conforming to global standard in the company's four priority fields: prostaglandins, enzyme inhibitors, neuroscience, and intracellular signaling.

Discovery Research Alliance, newly created in April 2005, is aggressively seeking and promoting alliances with bioventure companies and research institutions within and outside Japan in order to strengthen discovery research capability by gaining access to cutting-edge technologies and discovery seeds. This newly established section has already made achievements as launching collaborative drug discovery programs relating to inhibitors of kinase, one of the intracellular enzymes that is involved in various diseases, with two U.S. bioventure companies.

Further to that, Ono has made efforts to strengthen the development pipeline by acquiring in-licensing products aggressively. This time, International Business of Development Headquarters that has been in charge of inand out-licensing activities and Discovery Research Alliance of Research Headquarters that has pursued search and alliances of discovery seeds will be integrated in a constructive way into one unit as establishing Strategic Alliance Headquarters in order to further strengthen discovery research capability and expansion of development pipeline by promoting strategic alliances. Strategic Alliance Headquarters is anticipated to take an important role in improving overall research and development capability while closely coordinating with Research Headquarters and Development Headquarters.

https://www.chemeurope.com/en/news/62256/ono-pharmaceutical-announces-establishment-of-strategic-alliance-headquarters.html